291 related articles for article (PubMed ID: 15472192)
1. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.
Hansel B; Giral P; Nobecourt E; Chantepie S; Bruckert E; Chapman MJ; Kontush A
J Clin Endocrinol Metab; 2004 Oct; 89(10):4963-71. PubMed ID: 15472192
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity.
de Souza JA; Vindis C; Hansel B; Nègre-Salvayre A; Therond P; Serrano CV; Chantepie S; Salvayre R; Bruckert E; Chapman MJ; Kontush A
Atherosclerosis; 2008 Mar; 197(1):84-94. PubMed ID: 17868679
[TBL] [Abstract][Full Text] [Related]
3. A normotriglyceridemic, low HDL-cholesterol phenotype is characterised by elevated oxidative stress and HDL particles with attenuated antioxidative activity.
Kontush A; de Faria EC; Chantepie S; Chapman MJ
Atherosclerosis; 2005 Oct; 182(2):277-85. PubMed ID: 16159600
[TBL] [Abstract][Full Text] [Related]
4. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
Kontush A; de Faria EC; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
[TBL] [Abstract][Full Text] [Related]
5. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
[TBL] [Abstract][Full Text] [Related]
6. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
Nobécourt E; Jacqueminet S; Hansel B; Chantepie S; Grimaldi A; Chapman MJ; Kontush A
Diabetologia; 2005 Mar; 48(3):529-38. PubMed ID: 15729582
[TBL] [Abstract][Full Text] [Related]
7. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
[TBL] [Abstract][Full Text] [Related]
8. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.
Kontush A; Chantepie S; Chapman MJ
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1881-8. PubMed ID: 12920049
[TBL] [Abstract][Full Text] [Related]
9. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation.
Venojärvi M; Korkmaz A; Wasenius N; Manderoos S; Heinonen OJ; Lindholm H; Aunola S; Eriksson JG; Atalay M
Food Chem Toxicol; 2013 Nov; 61():127-35. PubMed ID: 23623841
[TBL] [Abstract][Full Text] [Related]
10. Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation.
Gómez Rosso L; Lhomme M; Meroño T; Sorroche P; Catoggio L; Soriano E; Saucedo C; Malah V; Dauteuille C; Boero L; Lesnik P; Robillard P; John Chapman M; Brites F; Kontush A
Atherosclerosis; 2014 Dec; 237(2):652-60. PubMed ID: 25463101
[TBL] [Abstract][Full Text] [Related]
11. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
Park KH; Shin DG; Kim JR; Hong JH; Cho KH
Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911
[TBL] [Abstract][Full Text] [Related]
12. The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects.
Dullaart RP; de Boer JF; Annema W; Tietge UJ
Obesity (Silver Spring); 2013 Feb; 21(2):361-6. PubMed ID: 23404653
[TBL] [Abstract][Full Text] [Related]
13. Increased oxidative stress in normal-weight postmenopausal women with metabolic syndrome compared with metabolically healthy overweight/obese individuals.
Kim M; Paik JK; Kang R; Kim SY; Lee SH; Lee JH
Metabolism; 2013 Apr; 62(4):554-60. PubMed ID: 23142163
[TBL] [Abstract][Full Text] [Related]
14. Association of serum lycopene and brachial-ankle pulse wave velocity with metabolic syndrome.
Yeo HY; Kim OY; Lim HH; Kim JY; Lee JH
Metabolism; 2011 Apr; 60(4):537-43. PubMed ID: 20580031
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.
Bortolasci CC; Vargas HO; Vargas Nunes SO; de Melo LG; de Castro MR; Moreira EG; Dodd S; Barbosa DS; Berk M; Maes M
J Affect Disord; 2015 Jul; 179():148-55. PubMed ID: 25863911
[TBL] [Abstract][Full Text] [Related]
16. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
17. Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c.
Gomez Rosso L; Lhomme M; Meroño T; Dellepiane A; Sorroche P; Hedjazi L; Zakiev E; Sukhorukov V; Orekhov A; Gasparri J; Chapman MJ; Brites F; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Feb; 1862(2):188-195. PubMed ID: 27815221
[TBL] [Abstract][Full Text] [Related]
18. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
[TBL] [Abstract][Full Text] [Related]
19. LDL subclass phenotypes and the risk factors of the insulin resistance syndrome.
Austin MA; Selby JV
Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S22-6. PubMed ID: 7550534
[TBL] [Abstract][Full Text] [Related]
20. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Kontush A; Chapman MJ
Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
